Biodexa Pharmaceuticals (BDRX) Cash from Investing Activities (2013 - 2022)

Biodexa Pharmaceuticals (BDRX) reported Cash from Investing Activities of -$19939.8 for Q4 2022, up 89.94% on a YoY basis from -$10498.1 in Q4 2021, and up 5.16% sequentially from -$21024.3 in Q3 2022.

Biodexa Pharmaceuticals (BDRX) Cash from Investing Activities (2013 - 2022) Analysis & Trends

Biodexa Pharmaceuticals (BDRX) has 8 years of Cash from Investing Activities data on file, last reported at -$19939.8 in Q4 2022.

  • For the quarter ending Q4 2022, Cash from Investing Activities rose 89.94% year-over-year to -$19939.8; the trailing twelve-month figure through Dec 2022 stood at -$443376.0 (up 29.56% YoY), and the FY2025 full-year result was -$768691.5, changed 0.15% from the prior year.
  • Cash from Investing Activities rose to -$19939.8 in Q4 2022, from -$21024.3 in the prior quarter.
  • In the past five years, Cash from Investing Activities ranged from a high of -$19939.8 in Q4 2022 to a low of -$1.3 million in Q4 2019.
  • A 4-year average of -$274669.8 and a median of -$116199.7 in 2020 frame the typical range for Cash from Investing Activities.
  • Across the five-year window, Cash from Investing Activities jumped 90.72% in 2020 and sank 84.32% in 2021, its largest moves.
  • Tracing BDRX's Cash from Investing Activities over 4 years: stood at -$1.3 million in 2019, then surged by 90.72% to -$116199.7 in 2020, then slumped by 70.53% to -$198157.6 in 2021, then surged by 89.94% to -$19939.8 in 2022.
  • Business Quant data shows BDRX's Cash from Investing Activities at -$19939.8 in Q4 2022, -$21024.3 in Q3 2022, and -$198157.6 in Q4 2021.
Generated on {Timestamp} © BusinessQuant.com
Generated on {Timestamp} Powered by BusinessQuant Logo

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Investing Activities (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn -45.51 Mn
4 NuCana 279.75 Bn 279.75 Bn - 178,242.27
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn -431.90 Mn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn -428.90 Mn
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn -
9 Revolution Medicines 37.78 Bn 37.78 Bn - 172.62 Mn
10 Biodexa Pharmaceuticals 18.43 Bn 18.43 Bn - -

Historic Data

Download Data
DateValue
Dec 31, 2022 -19,939.78
Dec 31, 2022 -19,939.78
Sep 14, 2022 -21,024.34
Sep 14, 2022 -21,024.34
Dec 31, 2021 -198,157.56
Dec 31, 2021 -198,157.56
Sep 17, 2021 -204,254.28
Sep 17, 2021 -204,254.28
Dec 31, 2020 -116,199.69
Dec 31, 2020 -116,199.69
Sep 10, 2020 -110,816.67
Sep 10, 2020 -110,816.67
Dec 31, 2019 -1.25 Mn
Dec 31, 2019 -1.25 Mn
Dec 31, 2016 -13,675.44
Dec 31, 2016 -13,675.44
Dec 31, 2015 -2.33 Mn
Dec 31, 2015 -2.33 Mn
Dec 31, 2014 -1.44 Mn
Dec 31, 2014 -1.44 Mn